RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference

19 Feb 2021 11:00 PM | Anonymous

https://www.biospace.com/article/releases/replicel-presents-its-technology-development-and-commercialization-plans-for-japan-at-kanagawa-regenerative-medicine-industry-conference/

© Copyright 2021 The Japan Society | All Rights Reserved | Privacy Policy

157 Adelaide Street West, Suite 604, Toronto, Ontario M5H 4E7 CANADA 
Tel: 416.366.4196 | admin@japansocietycanada.com


Powered by Wild Apricot Membership Software